<SEC-DOCUMENT>0001493152-18-006449.txt : 20180509
<SEC-HEADER>0001493152-18-006449.hdr.sgml : 20180509
<ACCEPTANCE-DATETIME>20180509093038
ACCESSION NUMBER:		0001493152-18-006449
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180509
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180509
DATE AS OF CHANGE:		20180509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Microbot Medical Inc.
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		18816923

	BUSINESS ADDRESS:	
		STREET 1:		175 DERBY ST. 27/1
		STREET 2:		.
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043
		BUSINESS PHONE:		908-938-5561

	MAIL ADDRESS:	
		STREET 1:		175 DERBY ST. 27/1
		STREET 2:		.
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STEMCELLS INC
		DATE OF NAME CHANGE:	20000524

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
the Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of Report (Date of earliest event reported): May 9, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
name of registrant as specified in its charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-19871</B></FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>94-3078125</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
                                         or other jurisdiction</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
        incorporation)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission</B></FONT></P>
                                                                             <P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
                                         Number)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(IRS
                                         Employer</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
        No.)</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25
                                         Recreation Park Drive, Unit 108</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hingham,
        Massachusetts 02043</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address
    of Principal Executive Offices) (Zip Code)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registrant&rsquo;s
telephone number, including area code: (781) 875-3605</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Former
Name or Former Address, if Changed Since Last Report)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
&sect;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
Growth Company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7.01 Regulation FD Disclosure.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 9, 2018, Microbot Medical Inc. (the &ldquo;Company&rdquo;) issued a press release announcing that the U.S. Patent and Trademark
Office has issued a Notice of Allowance for Patent Application No. 15/187,003, covering the Company&rsquo;s Self-Cleaning Shunt
(SCS)&trade; device.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be
&ldquo;filed&rdquo; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to
the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including
Exhibit 99.1).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9.01. Financial Statements and Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(d)
Exhibits</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 8%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT><FONT STYLE="font-size: 10pt"><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number</B></FONT></FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 90%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; vertical-align: top; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-1.htm">Press release, dated May 9, 2018</A></FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT
    MEDICAL INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Harel Gadot</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President and Chairman</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
May 9, 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.4pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 94; width: 250"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Microbot Medical Announces Receiving Notice
of Allowance for a U.S. Patent covering its<BR>
 Self-Cleaning Shunt (SCS)&trade; Device</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Hingham, MA &ndash; May 9, 2018 &ndash; Microbot
Medical Inc. (NASDAQ CM: MBOT), a medical device company specializing in the design and development of transformational micro-robotic
medical technologies, today announced the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Patent
Application No. 15/187,003, covering the Company&rsquo;s Self-Cleaning Shunt (SCS)&trade; device. The allowed application is a
Continuation of Patent No. 9,393,389, issued on July 19, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&ldquo;We are making the necessary moves as
we prepare for the next development phase of our Self-Cleaning Shunt, such as the recent move to our new R&amp;D facilities and
the expected studies&rsquo; results by the end of this quarter,&rdquo; commented Harel Gadot, CEO, President and Chairman. &ldquo;Protecting
our innovation remains a core principle to strengthening the device and Microbot&rsquo;s positioning and since we became a publicly-traded
company we have continued to establish and expand our IP portfolio globally. We believe the progression of our development and
the additional barriers to entry we continue to establish will secure our addressable market opportunities and enhance shareholder
value.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The allowed application covers an inlet head
for use on shunts, such as Ventriculoperitoneal (VP) Shunts, which are implanted in Hydrocephalus and NPH patients for draining
excess cerebrospinal fluid (CSF). The inlet head includes a tube with openings in its wall, and a cleaning element installed inside
the tube, such that vibratory motion of the cleaning element maintains clear openings, thereby expected to prevent shunt occlusion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>About Microbot Medical, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Microbot&trade;, which was founded in 2010
commenced operations in 2011, and became a NASDAQ listed company on November 28, 2016. The Company specializes in transformational
micro-robotic medical technologies leveraging the natural and artificial lumens within the human body. Microbot&rsquo;s current
platforms, ViRob&trade; and TipCAT&trade;, are comprised of two highly advanced micro-robotic technologies, from which the Company
is currently developing its first two product candidates: The Self-Cleaning Shunt&trade;, or SCS&trade;, for the treatment of hydrocephalus
and Normal Pressure Hydrocephalus, or NPH; and a self-propelling, semi-disposable endoscope that is being developed initially for
use in colonoscopy procedures. Further information about Microbot Medical&trade; is available at http://www.microbotmedical.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ViRob&trade; technology is a revolutionary
autonomous crawling micro-robot which can be controlled remotely or within the body. Its miniature dimensions allow it to navigate
and crawl in different spaces within the human body, including blood vessels, the digestive tract and the respiratory system. Its
unique structure gives it the ability to move in tight spaces and curved passages as well as the ability to remain within the human
body for prolonged time. To learn more about ViRob&trade; please visit http://www.microbotmedical.com/technology/virob/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">TipCAT&trade; is a transformational self-propelled,
flexible, and semi-disposable endoscope providing see &amp; treat capabilities within tubular lumens in the human body such as
the colon, blood vessels, and the urinary tract. Its locomotion mechanism is perfectly suitable to navigate and crawl through natural
&amp; artificial tubular lumens, applying the minimal necessary pressure to achieve the adequate friction required for gentle,
fast, and safe advancement within the human body. To learn more about TipCAT&trade; visit http://www.microbotmedical.com/technology/tipcat/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Safe Harbor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Statements pertaining to future financial
and/or operating results, future growth in research, technology, clinical development, and potential opportunities for Microbot
Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects
expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not
limited to statements that contain words such as &ldquo;will,&rdquo; &ldquo;believes,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;expects&rdquo; and &ldquo;estimates&rdquo;) should also be considered to be forward-looking statements. Forward-looking
statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization
of potential products, the outcome of its further evaluation of the CardioSert technology, uncertainty in the results of clinical
trials or regulatory approvals, need and ability to obtain future capital, and maintenance of intellectual property rights. Actual
results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated
together with the many uncertainties that affect the businesses of Microbot Medical Inc. particularly those mentioned in the cautionary
statements found in Microbot Medical Inc.&rsquo;s filings with the Securities and Exchange Commission. Microbot Medical disclaims
any intent or obligation to update these forward-looking statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Investor Contacts: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Analysts and Institutional Investors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Michael Polyviou</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">EVC Group</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">mpolyviou@evcgroup.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">732-232-6914</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Individual Investors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Jeremy Roe</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Integra Consulting Group llc</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">jeremy@integracg.net</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(925) 262-8305</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !N 28# 2(  A$! Q$!_\0
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J=;.UOX>,>YK6^&>3'?G! ++U_&N^6-%!"J!FA45/NJ!GTH =1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
